Kimberley Howard

Suggest Changes
Learn More
Recent successes as a pharmacological adjunct to exposure therapy has focused attention on the therapeutic potential of the glycine(B) receptor partial agonist, D-cycloserine (DCS), in certain(More)
  • 1